UBS Group AG - BIOLINERX LTD ownership

BIOLINERX LTD's ticker is BLRXXXXX and the CUSIP is 09071M106. A total of 38 filers reported holding BIOLINERX LTD in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
UBS Group AG ownership history of BIOLINERX LTD
ValueSharesWeighting
Q1 2019$5,000
+25.0%
11,822
+17.6%
0.00%
Q4 2018$4,000
-42.9%
10,054
+24.8%
0.00%
Q2 2018$7,000
-85.4%
8,056
-81.9%
0.00%
Q4 2017$48,000
+2300.0%
44,487
+2807.6%
0.00%
Q3 2017$2,000
-85.7%
1,530
-89.8%
0.00%
Q4 2016$14,000
+55.6%
15,038
+87.0%
0.00%
Q3 2016$9,000
-69.0%
8,042
-77.7%
0.00%
Q2 2016$29,000
+1350.0%
36,052
+2092.9%
0.00%
Q1 2016$2,000
-81.8%
1,644
-80.1%
0.00%
Q4 2015$11,000
+83.3%
8,243
+129.1%
0.00%
Q3 2015$6,000
-64.7%
3,598
-54.6%
0.00%
Q1 2015$17,0007,9270.00%
Other shareholders
BIOLINERX LTD shareholders Q4 2018
NameSharesValueWeighting ↓
BVF INC/IL 1,501,000$2,432,0000.47%
Senvest Management, LLC 2,278,995$3,692,0000.26%
Opaleye Management Inc. 250,000$405,0000.20%
SABBY MANAGEMENT, LLC 928,758$1,505,0000.05%
Benchmark Capital Advisors 40,000$65,0000.04%
Orbimed Advisors 1,135,000$1,839,0000.02%
NEXT Financial Group, Inc 28,500$46,0000.02%
Cutter & CO Brokerage, Inc. 10,000$16,0000.01%
Tower Research Capital LLC (TRC) 110$00.00%
Renaissance Technologies 26,878$44,0000.00%
View complete list of BIOLINERX LTD shareholders